Correspondence 0001437749-24-030891 from CervoMed Inc. (CRVO)
CervoMed Inc.
Date: Oct. 8, 2024 · CIK: 0001053691 · Accession: 0001437749-24-030891
AI Filing Summary & Sentiment
File numbers found in text: 333-282494
Show Raw Text
CORRESP 1 filename1.htm crvo20241008_corresp.htm CERVOMED INC. 20 Park Plaza Suite 424 Boston, MA 02116 October 8, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, DC 20549 Attention: Chris Edwards Re: CervoMed Inc. Registration Statement on Form S-3 (File No. 333-282494) Request for Acceleration of Effective Date Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, CervoMed Inc. (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) and declare the Registration Statement effective as of 5:00 p.m., Eastern Time, on October 10, 2024, or as soon as practicable thereafter. The Registrant requests that it be notified of such effectiveness by a telephone call to Jason S. McCaffrey, Esq., of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (617) 348-4416 or by an email to JSMcCaffrey@mintz.com. Thank you for your assistance. If you should have any questions, please contact Mr. McCaffrey at (617) 348-4416. Very truly yours, CERVOMED INC. By: /s/ William Elder Name: William Elder Title: Chief Financial Officer, General Counsel and Corporate Secretary